ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,629Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 1155

$565K Total Retail Price of All Prescriptions

Rank: 25 out of 1155

491 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 491 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

15% of this provider’s 491 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 11,053 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LEVOTHYROXINE SODIUM 635 543 1 2
LISINOPRIL 543 410 2 1
HYDROCHLOROTHIAZIDE 444 427 3 9
OMEPRAZOLE 426 328 4 5
SIMVASTATIN 418 351 5 3
SPIRONOLACTONE 406 388 6 55
ATORVASTATIN CALCIUM 399 353 7 12
FUROSEMIDE 381 342 8 8
HYDROCODONE-ACETAMINOPHEN 348 238 S3 9 4
METFORMIN HCL 343 266 10 7
AMLODIPINE BESYLATE 251 225 11 6
GABAPENTIN 231 164 12 15
ATENOLOL 229 207 13 10
METOPROLOL SUCCINATE 225 180 14 17
CARVEDILOL 199 197 15 28
SERTRALINE HCL 197 193 16 24
LOSARTAN POTASSIUM 183 162 17 18
GUANFACINE HCL 177 152 R 18 176
DONEPEZIL HCL 177 177 18 41
TRAZODONE HCL 177 143 18 22
SPIRONOLACTONE-HCTZ 166 162 21 161
PRAVASTATIN SODIUM 163 130 22 20
METOPROLOL TARTRATE 158 114 23 14
RANITIDINE HCL 155 137 24 33
FLUOXETINE HCL 148 45 25 30
ALLOPURINOL 138 92 26 29
OXYCODONE HCL 123 60 S2 27 23
GLIPIZIDE 117 96 28 44
ENALAPRIL MALEATE 115 101 29 66
ALENDRONATE SODIUM 106 96 30 25
POTASSIUM CHLORIDE 94 70 31 16
MICARDIS 93 93 32 169
LIPITOR 89 59 33 138
CITALOPRAM HBR 89 78 33 19
CHLORTHALIDONE 87 73 35 79
MIRTAZAPINE 86 74 36 61
WARFARIN SODIUM 85 84 37 11
FLOVENT HFA 84 68 38 158
PROPRANOLOL HCL 84 80 38 97
NAMENDA 81 81 40 67
PROAIR HFA 77 49 41 31
TRAMADOL HCL 75 62 42 32
ZOLPIDEM TARTRATE 73 65 43 21
FENOFIBRATE 73 53 43 83
SPIRIVA 71 46 45 49
LOVASTATIN 65 54 46 13
CRESTOR 65 61 46 34
AMITRIPTYLINE HCL 65 47 R 46 42
NOVOLOG 63 44 49 135
RISPERIDONE 61 61 50 73
INSULIN SYRINGE 61 34 50 90
DILTIAZEM 24HR ER 59 57 52 193
CYCLOBENZAPRINE HCL 59 34 R 52 38
VERAPAMIL ER 54 54 54 114
PAROXETINE HCL 53 44 55 48
MORPHINE SULFATE ER 52 23 S2 56 36
FLUTICASONE PROPIONATE 51 28 57 37
CLONIDINE HCL 50 27 58 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 27, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.